Market Research Industry Reports

Autolus Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Autolus Ltd (Autolus) is a biopharmaceutical company that develops anticancer therapies. The company uses T-cell programming and manufacturing technology to develop and commercialize T-cell therapies for cancer treatment. It uses chimeric antigen receptors (CARs) or T-cell receptors (TCRs) to regenerate the T-cell to recognize and assassin the cancer cells. Autoluss focuses on the research and development of chimeric antigen receptor (CAR) T-cell therapies for hematological malignancies and solid tumors. It seeks collaborations with academic institutions and industries to develop and deliver transformative T-cell immunotherapies. The company is funded by various companies such as syncona, arix bioscience, woodford investment management, cormorant asset management, and nextech invest among others. Autolus is headquartered in London, England, the UK.

Autolus Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Autolus Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autolus Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Autolus Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autolus Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Autolus Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Autolus Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Autolus Raises USD80 Million in Series C Financing 10
Autolus Raises USD56 Million in Series B Financing 12
Autolus Raises USD45.4 Million in Series A Financing 13
Licensing Agreements 14
Autolus Enters into Licensing Agreement with UCL Business 14
Equity Offering 15
Autolus Files Draft Registration Statement for IPO of Shares 15
Autolus Spin Out from University College London 16
Autolus Ltd - Key Employees 17
Autolus Ltd - Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Mar 12, 2018: Autolus Appoints Cynthia M. Butitta As Board Director 19
Jul 18, 2017: Autolus Announces Senior Leadership Appointments 20
Government and Public Interest 21
Mar 15, 2018: Autolus to support UK network of Advanced Therapies Treatment Centres 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List Of Tables

List of Tables
Autolus Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Autolus Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Autolus Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Autolus Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Autolus Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Autolus Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Autolus Raises USD80 Million in Series C Financing 10
Autolus Raises USD56 Million in Series B Financing 12
Autolus Raises USD45.4 Million in Series A Financing 13
Autolus Enters into Licensing Agreement with UCL Business 14
Autolus Files Draft Registration Statement for IPO of Shares 15
Autolus Spin Out from University College London 16
Autolus Ltd, Key Employees 17

List Of Figures

List of Figures
The Goodyear Tire & Rubber Company, Performance Chart (2013 - 2017) 31
The Goodyear Tire & Rubber Company, Ratio Charts 36

Autolus Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Autolus Ltd (Autolus) is a biopharmaceutical company that develops anticancer therapies. The company uses T-cell programming and manufacturing technology to develop and commercialize T-cell therapies for cancer treatment. It uses

USD 250View Report

BenevolentAI Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BenevolentAI Ltd(BenevolentAI), a technology company, develops artificial intelligence (AI) and a machine learning technology solution, which analyzes the data, test hypotheses, and draw conclusions. The company operates in two distinct

USD 250View Report

Medherant Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :22
Country :United Kingdom
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube